In this study, we did not find differences in intracellular total zinc or labile zinc concentrations between LIV-1 overexpressed and neo-control ARCaPE cells, suggesting that LIV-1 overexpression did not affect the intracellular zinc pool in prostate cancer cells. The gene discussed is SLC39A6; the disease is Familial prostate cancer.